Heart CT Follow-Up could cut heart attacks in Non-Obstructive disease

NCT ID NCT06843005

Recruiting now Disease control Sponsor: Zhang longjiang,MD Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether doing a follow-up CT scan of the heart arteries in people with non-obstructive coronary artery disease can help doctors adjust treatment to better control cholesterol and prevent heart attacks, strokes, or death. About 3,100 participants will be randomly assigned to either standard care or care guided by the CT scan results. The goal is to see if this imaging-based strategy improves outcomes over three years.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Coronary Computed Tomography Angiography (CCTA) scan
What this could lead to: If successful, this approach could help doctors personalize heart disease treatment based on plaque changes seen on CT scans, potentially reducing heart attacks and strokes.
What could go wrong: This is a large but early-stage study testing a management strategy, not a new drug. The benefit may be small, and the extra scans could lead to unnecessary procedures or anxiety.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE (CAD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder nonobstructive coronary artery disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CORONARY ARTERY DISEASE (CAD) CT ANGIOGRAPHY MAJOR ADVERSE CARDIOVASCULAR EVENTS (MACE) PREVENTION

Contacts and locations

Locations

Research Institute Of Medical Imaging Jinling Hospital
RECRUITING

Nanjing, Jiangsu, 210018, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.